
Syngene is a leading global CRDMO with over 30 years of experience solving complex R&D challenges, delivering integrated drug discovery, development and manufacturing services across small and large molecules, including niche modalities such as ADCs, peptides and oligonucleotides. The company offers elite-level client-centricity, a robust supply chain and scientific excellence at scale, partnering with global pharma and biotech leaders from discovery through commercial manufacturing to shape the future of science.

Aucun commentaire disponible.
Laissez votre note & commentaire